Skip to content
2000
Volume 23, Issue 9
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The liver represents the site of synthesis of most procoagulant and anticoagulant factors, fibrinolytic proteins and thrombopoetin while being also involved in the clearance of hemostatic and fibrinolyic proteins. Therefore in patients with liver insufficiency a great variety of disturbances can be documented resulting however in a new “rebalanced” hemostatic system with a labile equilibrium between thromboses or bleeding. Interestingly patients with liver insufficiency may present with arterial or venous thrombotic episodes requiring antiplatelet and/or antithrombotic therapy despite low platelet count or prolonged INR. The aim of this review is to point on the current knowledge regarding hemostasis in patients with liver insufficiency underlining practical recommendations of the use of antiplatelet and anticoagulant drugs in this setting.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612822666161205113629
2017-03-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612822666161205113629
Loading

  • Article Type:
    Research Article
Keyword(s): antiplatelets; antithrombotics; hemostasis rebalance; Liver insufficiency
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test